| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3
The hypothesis was tested that insulin sensitivity, previously shown to depend on a functional hepatic parasympathetic reflex, was mediated by hepatic production of nitric oxide (NO). Insulin sensitivity was measured using the rapid insulin sensitivity test. N-nitro-L-arginine methyl ester (L-NAME, 2.5 and 5.0 mg/kg iv) and N-monomethyl-L-arginine (L-NMMA, 0.73 mg/kg), nitric oxide synthase (NOS) antagonists, caused insulin resistance in rats. Intraportal administration of L-NAME at a dose of 1.0 mg/kg significantly reduced the response to insulin (54.9 ± 5.2%); however, administration of the same dose of L-NAME intravenously did not cause a significant decrease in insulin response. Intraportal, but not intravenous, administration of 3-morpholinosydnonimine (SIN-1, 5.0 mg/kg), a NO donor, partially reversed the insulin resistance caused by L-NMMA. Intraportal administration of SIN-1 (10.0 mg/kg) completely restored insulin sensitivity after L-NMMA or surgical denervation of the liver. Insulin resistance produced by denervation was not further increased by NOS blockade. These results suggest that blockade of NOS causes peripheral insulin resistance secondary to blockade of the hepatic parasympathetic reflex release of hepatic insulin-sensitizing substance in response to insulin.
diabetes; 3-morpholinosydnonimine; N-nitro-L-arginine methyl ester; N-monomethyl-L-arginine; parasympathetic nerves
This article has been cited by other articles:
|
|
 |
|
  M. C. Moore, C. A. DiCostanzo, M. S. Smith, B. Farmer, T. D. Rodewald, D. W. Neal, P. E. Williams, and A. D. Cherrington Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E768 - E777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. An, C. A. DiCostanzo, M. C. Moore, D. S. Edgerton, D. P. Dardevet, D. W. Neal, and A. D. Cherrington Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E300 - E306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Guarino, N. C. Correia, W. W. Lautt, and M. P. Macedo Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G527 - G532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Guarino, R. A. Afonso, N. Raimundo, J. F. Raposo, and M. P. Macedo Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G588 - G594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Moore, S. Satake, B. Baranowski, P.-S. Hsieh, D. W. Neal, and A. D. Cherrington Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E286 - E296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Lautt, M. P. Macedo, P. Sadri, S. Takayama, F. Duarte Ramos, and D. J. Legare Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G29 - G36. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
